TXMD - セラピュ―ティクスMD （TherapeuticsMD Inc.） セラピュ―ティクスMDTXMDのチャート
TXMDの企業情報
| symbol | TXMD |
|---|---|
| 会社名 | TherapeuticsMD Inc （セラピュ―ティクスMD） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | 医薬品 医療関連（Health Care） |
| 概要 | 事業概要 セラピーズMD(TherapeuticsMD Inc.)は女性用製品の創製・商品化に従事する女性のヘルスケア会社である。同社はホルモン療法の医薬品の商品化に必要な規制上の承認・商業化前の活動を行う。臨床試験で使用されるその薬物候補は、ホットフラッシュ、骨粗鬆症及び膣不快感を含む更年期関連ホルモン欠乏症の症状を緩和し、健康リスクを軽減するように設計されている。SYMBODA技術を用いて、同社は剤形および投与経路による生物同一ホルモンの送達を可能にするホルモン療法医薬品を開発している。同社の製品ラインは、vitaTrue、vitaPearl、vitaMedMD Plus、vitaMedMD One Prenatal Multivitamin、vitaMedMD Plus Rx Prenatal Multivitamin、vitaMedMD One Rx Prenatal Multivitamin、vitaMedMD Iron 21/7、vitaMedMD Vitamin D3 50 000 IU、BocaGreenMD Prena1 Pearl及びBocaGreenMD Prena1 Chewを含む。 セラピュ―ティクスMDは米国の医薬品企業。主に女性特有の疾患に関する医薬品の開発・商業化に従事する。臨床段階を経た新薬候補は、閉経に関するホルモン欠損症の症状を緩和する。同社はエストラジオ―ルとプロゲステロンを、単独または組み合わせるホルモン療法を開発する。また、ビタミンや鉄分のサプリメントも取り扱う。本社はフロリダ州ボカラトン。 TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing awareness of their healthcare issues. |
| 本社所在地 | 6800 Broken Sound Parkway N.W. Third Floor Boca Raton FL 33487 USA |
| 代表者氏名 | Tommy G. Thompson トミー・G・トンプソン |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 561-961-1911 |
| 設立年月日 | 1907年 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 173人 |
| url | www.therapeuticsmd.com |
| nasdaq_url | https://www.nasdaq.com/symbol/txmd |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -94.01541 |
| 終値（lastsale） | 5.88 |
| 時価総額（marketcap） | 1384225435.32 |
| 時価総額 | 時価総額（百万ドル） 1305.269 |
| 売上高 | 売上高（百万ドル） 16.07822 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 1224.02341 |
| 当期純利益 | 当期純利益（百万ドル） -93.71285 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 TherapeuticsMD Inc revenues decreased 8% to $7.5M. Net loss increased 41% to $57.6M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Selling general and administration increase of 60% to $50.2M (expense) Depreciation and amortization increase of 22% to $125K (expense). |
TXMDのテクニカル分析
TXMDのニュース
Gratifying stocks: Workhorse Group Inc. (NASDAQ:WKHS -2.45%), TherapeuticsMD, Inc. (NASDAQ:TXMD -11.01%) 2023/03/11 17:25:42 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Gratifying stocks: Workhorse Group Inc. (NASDAQ:WKHS -2.45%), TherapeuticsMD, Inc. (NASDAQ:TXMD -11.01%) appeared first on Stocks Equity .
Stocks Under Review: Cronos Group Inc. (NASDAQ:CRON -2.55%), TherapeuticsMD, Inc. (NASDAQ:TXMD -1.38%) 2023/03/10 18:59:33 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Stocks Under Review: Cronos Group Inc. (NASDAQ:CRON -2.55%), TherapeuticsMD, Inc. (NASDAQ:TXMD -1.38%) appeared first on Stocks Equity .
Global Bioidentical Hormones Market Size To Grow USD 10.10 Billion By 2030 | CAGR 6.50% 2023/03/09 18:00:00 GlobeNewswire
The Global Bioidentical Hormones Market Size was valued at USD 6.20 billion in 2021 and the worldwide bioidentical hormones market size is expected to reach USD 10.10 billion by 2030, according to a research report published by Spherical Insights & Consulting. Companies Covered:SottoPelle, Novartis AG, Orion Pharma AB, Full Life Wellness Center, BioTE Medical, LLC, Merck KGaA, Pfizer Inc., TherapeuticsMD, Inc., Papillon Medical, United Pharmacy, Noven Pharmaceuticals, Inc.GEA Group Aktiengesellschaft Novo Nordisk A/S, GeneScience Pharmaceuticals Co., Ltd., Actiza Pharmaceutical Private Limited, Defy Medical, Neuva Aesthetics, ZRT Laboratory, Bayer AG, Allergan and Among Others. The Global Bioidentical Hormones Market Size was valued at USD 6.20 billion in 2021 and the worldwide bioidentical hormones market size is expected to reach USD 10.10 billion by 2030, according to a research report published by Spherical Insights & Consulting. Companies Covered:SottoPelle, Novartis AG, Orion Pharma AB, Full Life Wellness Center, BioTE Medical, LLC, Merck KGaA, Pfizer Inc.
Current Stocks on Trader’s Radar: Pulmatrix, Inc. (NASDAQ:PULM -0.20%), TherapeuticsMD, Inc. (NASDAQ:TXMD 2.38%) 2023/02/23 16:37:06 Stock Equity
PULM has seen its SMA50 which is now -3.31%. In looking the SMA 200 we see that the stock has seen a -11.31%. TXMD has seen its SMA50 which is … The post Current Stocks on Trader’s Radar: Pulmatrix, Inc. (NASDAQ:PULM -0.20%), TherapeuticsMD, Inc. (NASDAQ:TXMD 2.38%) appeared first on Stocks Equity .
Current Sizzling Stocks Alert: Jaguar Health, Inc. (NASDAQ:JAGX), TherapeuticsMD, Inc. (NASDAQ:TXMD) 2023/02/23 15:42:10 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Current Sizzling Stocks Alert: Jaguar Health, Inc. (NASDAQ:JAGX), TherapeuticsMD, Inc. (NASDAQ:TXMD) appeared first on Stocks Equity .
Current Stocks on Trader’s Radar: Pulmatrix, Inc. (NASDAQ:PULM -0.20%), TherapeuticsMD, Inc. (NASDAQ:TXMD 2.38%) 2023/02/23 16:37:06 Stock Equity
PULM has seen its SMA50 which is now -3.31%. In looking the SMA 200 we see that the stock has seen a -11.31%. TXMD has seen its SMA50 which is … The post Current Stocks on Trader’s Radar: Pulmatrix, Inc. (NASDAQ:PULM -0.20%), TherapeuticsMD, Inc. (NASDAQ:TXMD 2.38%) appeared first on Stocks Equity .
Current Sizzling Stocks Alert: Jaguar Health, Inc. (NASDAQ:JAGX), TherapeuticsMD, Inc. (NASDAQ:TXMD) 2023/02/23 15:42:10 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Current Sizzling Stocks Alert: Jaguar Health, Inc. (NASDAQ:JAGX), TherapeuticsMD, Inc. (NASDAQ:TXMD) appeared first on Stocks Equity .
Overwhelming stocks: OceanPal Inc. (NASDAQ:OP), TherapeuticsMD, Inc. (NASDAQ:TXMD) 2023/02/16 11:08:45 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Overwhelming stocks: OceanPal Inc. (NASDAQ:OP), TherapeuticsMD, Inc. (NASDAQ:TXMD) appeared first on Stocks Equity .
Hot Stock of the Day: Kandi Technologies Group, Inc. (NASDAQ:KNDI -2.26%), TherapeuticsMD, Inc. (NASDAQ:TXMD -0.95%) 2023/02/04 13:47:32 Stock Equity
Kandi Technologies Group, Inc. (NASDAQ:KNDI) with the stream of -2.26% also noticed, India TherapeuticsMD, Inc. (NASDAQ:TXMD) encountered a rapid change of -0.95% in the last hour of Friday’s trading session. … The post Hot Stock of the Day: Kandi Technologies Group, Inc. (NASDAQ:KNDI -2.26%), TherapeuticsMD, Inc. (NASDAQ:TXMD -0.95%) appeared first on Stocks Equity .
TherapeuticsMD Inc. stock rises Tuesday, still underperforms market 2023/01/31 22:27:00 MarketWatch
Shares of TherapeuticsMD Inc. inched 0.96% higher to $5.27 Tuesday, on what proved to be an all-around positive trading session for the stock market, with…
TherapeuticsMD Inc. (NASDAQ:TXMD) Rises 34.90% In 2022; Is It Still Attractive At $7.09? 2022/12/17 15:30:00 Marketing Sentinel
In last trading session, TherapeuticsMD Inc. (NASDAQ:TXMD) saw 0.53 million shares changing hands with its beta currently measuring 1.28. Company’s recent per share price level of $7.09 trading at $0.46 or 6.94% at ring of the bell on the day assigns it a market valuation of $62.53M. That closing price of TXMD’s stock is at … TherapeuticsMD Inc. (NASDAQ:TXMD) Rises 34.90% In 2022; Is It Still Attractive At $7.09? Read More »
TherapeuticsMD Inc. stock falls Thursday, underperforms market 2022/12/15 22:28:00 MarketWatch
Shares of TherapeuticsMD Inc. slipped 5.29% to $6.63 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ…
This Insider Just Sold Shares of TherapeuticsMD Inc 2022/12/10 18:30:07 GuruFocus
Related Stocks: TXMD ,
The TherapeuticsMD Inc. (TXMD) had a good session last reading, didn’t it? 2022/12/06 12:32:00 US Post News
In Monday’s session, TherapeuticsMD Inc. (NASDAQ:TXMD) marked $5.12 per share, up from $4.45 in the previous session. While TherapeuticsMD Inc. has overperformed by 15.06%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, TXMD fell by -77.85%, with highs and lows ranging from $30.50 to $1.99, whereas […]